Clinical Trial Update: Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-finding study evaluating safety, pharmacokinetics, and dose optimization of a new therapy in advanced refractory solid tumors; currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Prostate Cancer

Snippet

Sponsor: MBrace Therapeutics | Conditions: Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING